Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Sofosbuvir-based Quadruple Regimen is Highly Effective in HCV Type 4-infected Egyptian Patients With DAA Treatment Failure

NCT04387539 is registered in ClinicalTrials.gov with Beni-Suef University as lead sponsor.

NCT NCT04387539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04387539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Sofosbuvir-based Quadruple Regimen is Highly Effective in HCV Type 4-infected Egyptian Patients With DAA Treatment Failure
Lead sponsor
Beni-Suef University
Phase
Phase 1/2
Overall status
Completed
Start date
March 1, 2017
Completion date
October 31, 2017
Enrollment
94 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c virus infection